ADISO
InactiveInactive since 18-08-2026; last annual accounts for fiscal year 2024.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
32 d early
2024
34 d early
2023
6 d early
2022
4 d early
2021
11 d early
2020
2 d early
2019
41 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 7 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
What became of the directors' other companies?Supplier due diligence Who ran this company, and where was it based, on a date before the end?Company as of a date Which other companies belong to the same group?KORYS · 159 companies How is the Business and other management consultancy sector doing?Sector figures
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, full schema
Turnover
€12,000
EBIT margin
35.7%
Net result
€61,574▲ 23.9%
2023 · €49,691
Working capital
€2.6m▲ 2.3%
2023 · €2.6m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Turnover€12,000
Operating result€631,407▼ 0.2%€626,304▼ 0.8%€513,420▼ 18.0%-€5,128€4,286
Net result€798,495above the sector's middle half▲ 81.7%€975,769above the sector's middle half▲ 22.2%€395,116above the sector's middle half▼ 59.5%€49,691within the sector's middle half▼ 87.4%€61,574within the sector's middle half▲ 23.9%
EBIT margin35.7%
Equity€2.6mabove the sector's middle half▲ 30.7%€3.2mabove the sector's middle half▲ 20.8%€3.5mabove the sector's middle half▲ 8.2%€3.5mabove the sector's middle half▲ 1.4%€3.6mabove the sector's middle half▲ 1.8%
Total assets€2.6mabove the sector's middle half▲ 25.0%€3.3mabove the sector's middle half▲ 24.7%€3.5mabove the sector's middle half▲ 5.5%€3.5mabove the sector's middle half▲ 0.7%€3.6mwithin the sector's middle half▲ 1.7%
Debt€3,685▼ 96.1%€106,230▲ 2,783%€27,855▼ 73.8%€3,940▼ 85.9%€936▼ 76.3%
Working capital€1.3mabove the sector's middle half▲ 87.2%€2.0mabove the sector's middle half▲ 50.5%€2.5mabove the sector's middle half▲ 25.6%€2.6mabove the sector's middle half▲ 2.2%€2.6mabove the sector's middle half▲ 2.3%
Solvency99.9%above the sector's middle half▲ 4.3pp96.8%above the sector's middle half▼ 3.1pp99.2%above the sector's middle half▲ 2.4pp99.9%above the sector's middle half▲ 0.7pp100.0%above the sector's middle half▲ 0.1pp
Current ratio19.91above the sector's middle half91.35above the sector's middle half▲ 71.44
Return on assets (ROA)30.2%above the sector's middle half▲ 9.4pp29.6%above the sector's middle half▼ 0.6pp11.4%within the sector's middle half▼ 18.2pp1.4%within the sector's middle half▼ 9.9pp1.7%within the sector's middle half▲ 0.3pp
Staff (FTE)0below the sector's middle half0within the sector's middle half
above
within
below
the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2024: €4,286 after a loss of €5,128 in 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €3.6m
Fixed assets
€933,476 ▼ 0.2%
Current assets
€2.6m ▲ 2.3%
Equity and liabilities €3.6m
Equity
€3.6m ▲ 1.8%
Debt
€936 ▼ 76.3%
Debt's share of the balance-sheet total falls from 0.1% to 0.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€5,786▲
2023 · -€3,628
Cash flow
€63,074▲
2023 · €51,191
Debt to equity
0.00▼
2023 · 0.00
ROE
1.7%▲
2023 · 1.4%
Interest coverage
7418.36▲
2023 · -3.48
Debt ≤ 1 year
€936▲
2023 · €600
Income taxes
€20,708▲
2023 · €16,869
A ratio outside any meaningful range has been withheld (balance sheet total €3.6m, equity €3.6m).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | - | - | - | - | €12,000 | - |
| Turnover70 | - | - | - | - | €12,000 | - |
| Other operating income74 | - | - | - | - | €0 | - |
| Non-recurring operating income76A | - | - | €33,400 | €0 | - | - |
| Operating charges60/66A | - | - | - | - | €7,714 | - |
| Services and other goods61 | - | - | - | - | €3,981 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €35,501 | €35,695 | €1,500 | €1,500 | €1,500 | = |
| Other operating charges640/8 | - | €2,796 | €5,980 | €1,092 | €2,233 | ▲ 104% |
| Gross operating margin9900 | €669,798 | €664,795 | €520,900 | -€2,536 | - | - |
| Operating profit (loss)9901 | €631,407 | €626,304 | €513,420 | -€5,128 | €4,286 | ▲ 184% |
| Financial income75/76B | - | €504,125 | €15,433 | €72,731 | €78,844 | ▲ 8.4% |
| Recurring financial income75 | €400,802 | €504,125 | €15,433 | €72,731 | €78,844 | ▲ 8.4% |
| Income from current assets751 | - | - | - | - | €47,907 | - |
| Other financial income752/9 | - | - | - | - | €30,938 | - |
| Financial charges65/66B | - | €2,032 | €382 | €1,043 | €848 | ▼ 18.7% |
| Recurring financial charges65 | €431 | €2,032 | €382 | €1,043 | €848 | ▼ 18.7% |
| Debt charges650 | - | - | - | - | €1 | - |
| Other financial charges652/9 | - | - | - | - | €847 | - |
| Profit (loss) for the period before taxes9903 | €1.0m | €1.1m | €528,471 | €66,560 | €82,282 | ▲ 23.6% |
| Income taxes67/77 | €233,283 | €152,627 | €133,355 | €16,869 | €20,708 | ▲ 22.8% |
| Taxes670/3 | - | - | - | - | €20,708 | - |
| Profit (loss) for the period9904 | €798,495 | €975,769 | €395,116 | €49,691 | €61,574 | ▲ 23.9% |
| Profit (loss) for the period to be appropriated9905 | €798,495 | €975,769 | €395,116 | €49,691 | €61,574 | ▲ 23.9% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €2.6m | €3.3m | €3.5m | €3.5m | €3.6m | ▲ 1.7% |
| Fixed assets21/28 | €1.3m | €1.2m | €936,476 | €934,976 | €933,476 | ▼ 0.2% |
| Tangible fixed assets22/27 | €531,605 | €518,862 | €265,017 | €263,517 | €262,017 | ▼ 0.6% |
| Land and buildings22 | - | €269,899 | €13,500 | €12,000 | €10,500 | ▼ 12.5% |
| Other tangible fixed assets26 | - | €248,963 | €251,517 | €251,517 | €251,517 | = |
| Financial fixed assets28 | €779,959 | €669,959 | €671,459 | €671,459 | €671,459 | = |
| Affiliated companies280/1 | - | - | - | - | €671,459 | - |
| Participating interests280 | - | - | - | - | €671,459 | - |
| Current assets29/58 | €1.3m | €2.1m | €2.5m | €2.6m | €2.6m | ▲ 2.3% |
| Amounts receivable after more than one year29 | - | €30,000 | €0 | - | - | - |
| Other amounts receivable291 | - | €30,000 | €0 | - | - | - |
| Stocks and contracts in progress3 | - | - | - | - | €0 | - |
| Amounts receivable within one year40/41 | €498,938 | €2.0m | €151,266 | €26,360 | €2.3m | ▲ 8,460% |
| Trade receivables40 | - | €577,241 | €15,898 | €8,524 | €3,630 | ▼ 57.4% |
| Other amounts receivable41 | - | €1.4m | €135,368 | €17,836 | €2.3m | ▲ 12,531% |
| Current investments50/53 | €147 | €0 | €2.3m | €2.5m | €340,000 | ▼ 86.5% |
| Other investments51/53 | - | - | - | - | €340,000 | - |
| Cash at bank and in hand54/58 | €835,106 | €120,554 | €107,835 | €8,501 | €3,954 | ▼ 53.5% |
| Deferred charges and accrued income490/1 | - | €6,442 | €15,432 | €12,108 | €31,471 | ▲ 160% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €2.6m | €3.3m | €3.5m | €3.5m | €3.6m | ▲ 1.7% |
| Equity10/15 | €2.6m | €3.2m | €3.5m | €3.5m | €3.6m | ▲ 1.8% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €2.6m | €3.2m | €3.4m | €3.4m | €3.4m | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Tax-exempt reserves132 | - | €2,253 | €2,253 | €2,253 | €2,253 | = |
| Distributable reserves133 | - | €3.2m | €3.4m | €3.4m | €3.4m | = |
| Profit (loss) carried forward14 | - | €0 | €0 | €49,691 | €111,265 | ▲ 124% |
| Amounts payable17/49 | €3,685 | €106,230 | €27,855 | €3,940 | €936 | ▼ 76.3% |
| Amounts payable within one year42/48 | €3,435 | €105,980 | €27,855 | €600 | €936 | ▲ 55.9% |
| Trade debts44 | €3,435 | €554 | €1,004 | €300 | €636 | ▲ 112% |
| Suppliers440/4 | - | €554 | €1,004 | €300 | €636 | ▲ 112% |
| Advances received on contracts in progress46 | - | - | €24,659 | €0 | - | - |
| Taxes, remuneration and social security45 | - | €99,939 | €0 | - | - | - |
| Taxes450/3 | - | €99,939 | €0 | - | - | - |
| Other amounts payable47/48 | - | €5,487 | €2,192 | €300 | €300 | = |
| Accrued charges and deferred income492/3 | - | €250 | €0 | €3,340 | €0 | ▼ 100% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €798,495 | €975,769 | €395,116 | €49,691 | €61,574 | ▲ 23.9% |
| + Depreciation and write-downs630 | €35,501 | €35,695 | €1,500 | €1,500 | €1,500 | = |
| Operating cash flow (approximation) | €833,996 | €1.0m | €396,616 | €51,191 | €63,074 | ▲ 23.2% |
| Investment in fixed assets (approximation) | - | €87,048 | €250,845 | €0 | €0 | - |
| Change in cash | - | -€714,552 | -€12,719 | -€99,334 | -€4,546 | ▲ 95.4% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-08
State Gazette act
Restructuring · End & cessationResignations: PHARCOSSOL (director) and INFINOVA (director) · Permanent representatives: Marc MONTEYNE and Luc ADRIAENSSENS · Merger11 facts ▸
State Gazette act
Restructuring · End & cessation
Resignations: PHARCOSSOL (director) and INFINOVA (director) · Permanent representatives: Marc MONTEYNE and Luc ADRIAENSSENS · Merger11 facts ▸
- General meeting, 30-07-2026
- Merger, met fusie door overneming gelijkgestelde verrichting, overnemende vennootschap is enige aandeelhouder
- Director resignation, PHARCOSSOL (director)
- Director resignation, INFINOVA (director)
- Permanent representative, Marc MONTEYNE (permanent representative)
- Permanent representative, Luc ADRIAENSSENS (permanent representative)
- Director discharge, PHARCOSSOL
- Director discharge, INFINOVA
- Director discharge, Marc MONTEYNE
- Director discharge, Luc ADRIAENSSENS
- Power of attorney
29-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
12-06
State Gazette act
RestructuringPermanent representative: Luc Adriaenssens · Merger · Shareholding17 facts ▸
State Gazette act
Restructuring
Permanent representative: Luc Adriaenssens · Merger · Shareholding17 facts ▸
- Merger, fusie door overneming, rechten en verplichtingen
- Shareholding, INNOVATIVE FOOD & HEALTH SOLUTIONS
- Incorporation, 10-08-2022
- Statutes amendment
- Capital
- Incorporation, 02-01-2006
- Statutes amendment
- Capital
- Accounting effect, 01-01-2026
- Other statement, bijzondere rechten over te nemen vennootschap, artikel 12:50, 3° WWV
- Other statement, bijzondere voordelen bestuursorganen, artikel 12:50, 4° WWV
- Statutes amendment
- +5 further facts in this act
2025
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Weakest financial yearnet €49,691 ▼87.4%
Net result drops to €49,691, the lowest in the series.
31-12
Financial
Liquidity times 47current ratio 4285.79
Current ratio from 91.35 to 4285.79; short-term debt falls from €27,855 to €600.
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Liquidity times 5current ratio 91.35
Current ratio from 19.91 to 91.35; short-term debt falls from €105,980 to €27,855.
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €975,769 ▲22.2%
Net result €975,769, the highest in the series.
29-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
Show earlier events
2020
31-12
Financial
Liquidity times 42current ratio 388.67
Current ratio from 9.28 to 388.67; short-term debt falls from €85,892 to €3,435.
10-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 41 days late
2019
31-12
Financial
Liquidity triplescurrent ratio 9.28
Current ratio from 2.75 to 9.28; short-term debt falls from €192,839 to €85,892.
31-12
Financial
Equity above €2mEq €2.0m ▲26.9%
2 profitable years in a row build equity to €2.0m.
28-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 28 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 30 days late
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 25 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
2 of 7 acts read
About the unread acts
Of the 7 Belgian State Gazette acts we know for this company, 2 have been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
no sitting director, last change in 2026
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Not every act has been read: a resignation may be missing here
5 of this company's 7 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Nazareth-De Pinte
Ground area
1,077 m²
Building footprint
207 m²
Volume, LiDAR
118 m³
Parcel 44079B0059/00E000, Flanders · tallest building 3.2 m. Linked by address, not a title deed.
4
companies at this address
See who is registered here
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44079B0059/00E000 | Flanders | 1,077 m² | 1 · 207 m² | 3.2 m |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
2 people since 2026, 0 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| INFINOVA |
|
| PHARCOSSOL |
|
Articles of association
Who signs
Each director alone
Accounting effect
01-01-2026
Other statement
Bestuursorganen betrokken vennootschappen, alle nuttige informatie
2 more provisions on this in the deed
Structure & network
Part of the group
KORYS
159 companies
Group, risk and exposure
Owners and holdings
1 owner · 1 holdingChain of control
Highest known parent: KORYS. The sources do not say who stands above it.
Owners 1
- 100%
Holdings 1
-
100%
According to the 2024 annual accounts of ADISO and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Acquisitions and mergers
1 transactionTaken over by:Innovative Food & Health Solutions
Capital and shareholders
Shareholders according to the acts
Stated in the act
act of 12-06-2026 ↗
- INNOVATIVE FOOD & HEALTH SOLUTIONS (BE 0789.546.940) all shares
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 12-06-2026 Capital stated in the act · 186,000 shares
Similar companies · same sector, comparable size
M.J.S. CONSULTING
BE 0442.767.485
Knokke-Heist · Eq €3,564,714
SUBUNA
BE 0891.228.179
Ukkel · Eq €3,564,812
MD CONSULT
BE 0471.608.456
Knokke-Heist · Eq €3,563,156
CARBOR
BE 0864.569.512
Namur · Eq €3,562,462
Art of Things
BE 0467.223.858
Brussel · Eq €3,562,372
Of 82,646 companies in sector 70200 we hold annual accounts for 52,627. 14,197 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded02-01-2006
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0878312630
Registered
27-03-2026
The company is no longer active; its Peppol card can remain until its access point withdraws it.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.